Literature DB >> 16807353

Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs.

Anabel Gil1, Amparo Andrés-Pons, Elena Fernández, Miguel Valiente, Josema Torres, Javier Cervera, Rafael Pulido.   

Abstract

The targeting of the tumor suppressor PTEN protein to distinct subcellular compartments is a major regulatory mechanism of PTEN function, by controlling its access to substrates and effector proteins. Here, we investigated the molecular basis and functional consequences of PTEN nuclear/cytoplasmic distribution. PTEN accumulated in the nucleus of cells treated with apoptotic stimuli. Nuclear accumulation of PTEN was enhanced by mutations targeting motifs in distinct PTEN domains, and it was dependent on an N-terminal nuclear localization domain. Coexpression of a dominant negative Ran GTPase protein blocked PTEN accumulation in the nucleus, which was also affected by coexpression of importin alpha proteins. The lipid- and protein-phosphatase activity of PTEN differentially modulated PTEN nuclear accumulation. Furthermore, catalytically active nuclear PTEN enhanced cell apoptotic responses. Our findings indicate that multiple nuclear exclusion motifs and a nuclear localization domain control PTEN nuclear localization by a Ran-dependent mechanism and suggest a proapoptotic role for PTEN in the cell nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807353      PMCID: PMC1556382          DOI: 10.1091/mbc.e06-05-0380

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  72 in total

1.  Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis.

Authors:  Satoru Funamoto; Ruedi Meili; Susan Lee; Lisa Parry; Richard A Firtel
Journal:  Cell       Date:  2002-05-31       Impact factor: 41.582

2.  Tumor suppressor PTEN mediates sensing of chemoattractant gradients.

Authors:  Miho Iijima; Peter Devreotes
Journal:  Cell       Date:  2002-05-31       Impact factor: 41.582

3.  PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.

Authors:  Lindsey D Mayo; Jack E Dixon; Donald L Durden; Nickolas K Tonks; David B Donner
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

4.  Direct identification of PTEN phosphorylation sites.

Authors:  Susan J Miller; David Y Lou; David C Seldin; William S Lane; Benjamin G Neel
Journal:  FEBS Lett       Date:  2002-09-25       Impact factor: 4.124

5.  Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.

Authors:  David C Whiteman; Xiao-Ping Zhou; Margaret C Cummings; Sandra Pavey; Nicholas K Hayward; Charis Eng
Journal:  Int J Cancer       Date:  2002-05-01       Impact factor: 7.396

Review 6.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.

Authors:  Elaine A Orchiston; Deborah Bennett; Nick R Leslie; Rosemary G Clarke; Lucinda Winward; C Peter Downes; Stephen T Safrany
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

8.  Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation.

Authors:  Diana Birle; Nunzio Bottini; Scott Williams; Huong Huynh; Ian deBelle; Eileen Adamson; Tomas Mustelin
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.

Authors:  Makoto Sumitomo; Akira Iwase; Rong Zheng; Daniel Navarro; David Kaminetzky; Ruoqian Shen; Maria-Magdalena Georgescu; David M Nanus
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

Review 10.  The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.

Authors:  Lindsey D Mayo; David B Donner
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

View more
  58 in total

1.  Therapeutic targeting of cancers with loss of PTEN function.

Authors:  Lloye M Dillon; Todd W Miller
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

2.  Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.

Authors:  Byeong Hyeok Choi; Yan Chen; Wei Dai
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

3.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

4.  Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.

Authors:  Amit Kumar; Javier Redondo-Muñoz; Vicente Perez-García; Isabel Cortes; Monica Chagoyen; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

Review 5.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

6.  Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells.

Authors:  Saskia M Brachmann; Irmgard Hofmann; Christian Schnell; Christine Fritsch; Susan Wee; Heidi Lane; Shaowen Wang; Carlos Garcia-Echeverria; Sauveur-Michel Maira
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

7.  Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.

Authors:  Hacer Guvenc; Marat S Pavlyukov; Kaushal Joshi; Habibe Kurt; Yeshavanth K Banasavadi-Siddegowda; Ping Mao; Christopher Hong; Ryosuke Yamada; Chang-Hyuk Kwon; Deepak Bhasin; Somsundaram Chettiar; Gaspar Kitange; In-Hee Park; Jann N Sarkaria; Chenglong Li; Mihail I Shakhparonov; Ichiro Nakano
Journal:  Clin Cancer Res       Date:  2012-12-18       Impact factor: 12.531

8.  The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.

Authors:  Fatemeh Fouladkou; Tamara Landry; Hiroshi Kawabe; Antje Neeb; Chen Lu; Nils Brose; Vuk Stambolic; Daniela Rotin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

Review 9.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

10.  Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance.

Authors:  Lili Wang; Chenxu Wang; Shanshan Jin; Donghui Qu; Huanchun Ying
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.